Institute of Biomedical Research Corp. (MRES)
OTCMKTS · Delayed Price · Currency is USD
0.0017
0.00 (0.00%)
May 20, 2026, 2:06 PM EST
MRES Market Cap
MRES has a market cap or net worth of $4.67 million as of May 21, 2026. Its market cap has decreased by -88.77% in one year.
Market Cap
4.67M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 31, 2016, MRES's market cap has increased from 693.95K to 4.67M, an increase of 573.51%. That is a compound annual growth rate of 20.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 4.67M | -39.29% |
| Dec 31, 2025 | 7.70M | -83.96% |
| Dec 31, 2024 | 47.98M | 138.03% |
| Dec 29, 2023 | 20.16M | 17.54% |
| Dec 30, 2022 | 17.15M | 149.69% |
| Dec 31, 2021 | 6.87M | 971.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synlogic | 7.72M |
| Brainstorm Cell Therapeutics | 7.61M |
| BetterLife Pharma | 7.26M |
| TRON Group | 7.18M |
| Nymox Pharmaceutical | 5.41M |
| Reviva Pharmaceuticals Holdings | 5.25M |
| Mosaic ImmunoEngineering | 5.03M |
| Adaptimmune Therapeutics | 5.01M |